Logo image of SENEB

SENECA FOODS CORP - CL B (SENEB) Stock Fundamental Analysis

NASDAQ:SENEB - Nasdaq - US8170701051 - Common Stock - Currency: USD

99.99  +5.99 (+6.37%)

Fundamental Rating

4

Taking everything into account, SENEB scores 4 out of 10 in our fundamental rating. SENEB was compared to 90 industry peers in the Food Products industry. SENEB has only an average score on both its financial health and profitability. SENEB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year SENEB was profitable.
SENEB had a positive operating cash flow in the past year.
SENEB had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: SENEB reported negative operating cash flow in multiple years.
SENEB Yearly Net Income VS EBIT VS OCF VS FCFSENEB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

The Return On Assets of SENEB (2.79%) is comparable to the rest of the industry.
SENEB has a Return On Equity of 6.90%. This is comparable to the rest of the industry: SENEB outperforms 60.00% of its industry peers.
SENEB's Return On Invested Capital of 5.59% is fine compared to the rest of the industry. SENEB outperforms 61.11% of its industry peers.
SENEB had an Average Return On Invested Capital over the past 3 years of 4.61%. This is below the industry average of 7.59%.
The 3 year average ROIC (4.61%) for SENEB is below the current ROIC(5.59%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.79%
ROE 6.9%
ROIC 5.59%
ROA(3y)3.4%
ROA(5y)5.95%
ROE(3y)6.82%
ROE(5y)11.08%
ROIC(3y)4.61%
ROIC(5y)6.89%
SENEB Yearly ROA, ROE, ROICSENEB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

SENEB's Profit Margin of 2.79% is in line compared to the rest of the industry. SENEB outperforms 57.78% of its industry peers.
In the last couple of years the Profit Margin of SENEB has grown nicely.
The Operating Margin of SENEB (5.67%) is better than 61.11% of its industry peers.
SENEB's Operating Margin has declined in the last couple of years.
The Gross Margin of SENEB (10.82%) is worse than 71.11% of its industry peers.
In the last couple of years the Gross Margin of SENEB has grown nicely.
Industry RankSector Rank
OM 5.67%
PM (TTM) 2.79%
GM 10.82%
OM growth 3Y-10.74%
OM growth 5YN/A
PM growth 3Y-20.29%
PM growth 5Y54.53%
GM growth 3Y-6.57%
GM growth 5Y31.41%
SENEB Yearly Profit, Operating, Gross MarginsSENEB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SENEB is destroying value.
The number of shares outstanding for SENEB has been reduced compared to 1 year ago.
Compared to 5 years ago, SENEB has less shares outstanding
The debt/assets ratio for SENEB is higher compared to a year ago.
SENEB Yearly Shares OutstandingSENEB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
SENEB Yearly Total Debt VS Total AssetsSENEB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.88 indicates that SENEB is not a great score, but indicates only limited risk for bankruptcy at the moment.
SENEB has a better Altman-Z score (2.88) than 67.78% of its industry peers.
SENEB has a debt to FCF ratio of 13.12. This is a negative value and a sign of low solvency as SENEB would need 13.12 years to pay back of all of its debts.
The Debt to FCF ratio of SENEB (13.12) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.73 indicates that SENEB is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.73, SENEB is not doing good in the industry: 64.44% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 13.12
Altman-Z 2.88
ROIC/WACC0.6
WACC9.34%
SENEB Yearly LT Debt VS Equity VS FCFSENEB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 2.64 indicates that SENEB has no problem at all paying its short term obligations.
SENEB has a better Current ratio (2.64) than 77.78% of its industry peers.
A Quick Ratio of 0.33 indicates that SENEB may have some problems paying its short term obligations.
SENEB has a Quick ratio of 0.33. This is amonst the worse of the industry: SENEB underperforms 87.78% of its industry peers.
Industry RankSector Rank
Current Ratio 2.64
Quick Ratio 0.33
SENEB Yearly Current Assets VS Current LiabilitesSENEB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.94% over the past year.
The Earnings Per Share has been growing by 70.18% on average over the past years. This is a very strong growth
The Revenue has decreased by -1.85% in the past year.
Measured over the past years, SENEB shows a small growth in Revenue. The Revenue has been growing by 3.99% on average per year.
EPS 1Y (TTM)23.94%
EPS 3Y-14.39%
EPS 5Y70.18%
EPS Q2Q%-42.13%
Revenue 1Y (TTM)-1.85%
Revenue growth 3Y-0.2%
Revenue growth 5Y3.99%
Sales Q2Q%4.41%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SENEB Yearly Revenue VS EstimatesSENEB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.12, which indicates a rather expensive current valuation of SENEB.
SENEB's Price/Earnings ratio is a bit cheaper when compared to the industry. SENEB is cheaper than 62.22% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.86. SENEB is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.12
Fwd PE N/A
SENEB Price Earnings VS Forward Price EarningsSENEB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SENEB indicates a somewhat cheap valuation: SENEB is cheaper than 62.22% of the companies listed in the same industry.
71.11% of the companies in the same industry are more expensive than SENEB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.61
EV/EBITDA 9.56
SENEB Per share dataSENEB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.24
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SENEB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SENECA FOODS CORP - CL B

NASDAQ:SENEB (6/26/2025, 8:27:30 PM)

99.99

+5.99 (+6.37%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-05 2025-02-05
Earnings (Next)06-12 2025-06-12
Inst Owners54.25%
Inst Owner Change-2.23%
Ins Owners2.99%
Ins Owner Change0%
Market Cap687.93M
Analysts0
Price TargetN/A
Short Float %0.03%
Short Ratio0.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0.08%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.12
Fwd PE N/A
P/S 0.46
P/FCF 16.61
P/OCF 9.94
P/B 1.15
P/tB 1.15
EV/EBITDA 9.56
EPS(TTM)5.84
EY5.84%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)6.02
FCFY6.02%
OCF(TTM)10.06
OCFY10.06%
SpS215.5
BVpS87.06
TBVpS87.06
PEG (NY)N/A
PEG (5Y)0.24
Profitability
Industry RankSector Rank
ROA 2.79%
ROE 6.9%
ROCE 7.82%
ROIC 5.59%
ROICexc 5.64%
ROICexgc 5.64%
OM 5.67%
PM (TTM) 2.79%
GM 10.82%
FCFM 2.79%
ROA(3y)3.4%
ROA(5y)5.95%
ROE(3y)6.82%
ROE(5y)11.08%
ROIC(3y)4.61%
ROIC(5y)6.89%
ROICexc(3y)4.66%
ROICexc(5y)7.18%
ROICexgc(3y)4.66%
ROICexgc(5y)7.18%
ROCE(3y)6.48%
ROCE(5y)9.65%
ROICexcg growth 3Y-26.63%
ROICexcg growth 5YN/A
ROICexc growth 3Y-26.63%
ROICexc growth 5YN/A
OM growth 3Y-10.74%
OM growth 5YN/A
PM growth 3Y-20.29%
PM growth 5Y54.53%
GM growth 3Y-6.57%
GM growth 5Y31.41%
F-Score8
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 13.12
Debt/EBITDA 3.41
Cap/Depr 63.59%
Cap/Sales 1.87%
Interest Coverage 250
Cash Conversion 54.15%
Profit Quality 100.21%
Current Ratio 2.64
Quick Ratio 0.33
Altman-Z 2.88
F-Score8
WACC9.34%
ROIC/WACC0.6
Cap/Depr(3y)134.39%
Cap/Depr(5y)167.24%
Cap/Sales(3y)3.68%
Cap/Sales(5y)4.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.94%
EPS 3Y-14.39%
EPS 5Y70.18%
EPS Q2Q%-42.13%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.85%
Revenue growth 3Y-0.2%
Revenue growth 5Y3.99%
Sales Q2Q%4.41%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.61%
EBIT growth 3Y-10.92%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y136.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y229.6%
OCF growth 3YN/A
OCF growth 5YN/A